Jessica A Meisner, MD, MS, MSHP
Assistant Professor of Clinical Medicine
Department: Medicine
Contact information
Hospital of the University of Pennsylvania, 3400 Spruce Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
Program (War Studies)
King's College of London, London, United Kingdom, 2006.
BA (Biological Sciences)
University of Southern California, Los Angeles, CA, 2007.
BA (International Relations)
University of Southern California, Los Angeles, CA, 2007.
MS (Biohazardous Threat Agents and Emerging Infectious Diseases)
Georgetown University, Washington, DC, 2008.
MD
Drexel University, College of Medicine, Philadelphia, PA, 2013.
Certificat (Global Health Delivery Intensive Certificate)
Harvard School of Public Health, Boston MA, 2014.
MSHP (Healthcare Quality and Safety concentration)
University of Pennsylvania, Philadelphia, PA, 2019.
Permanent linkProgram (War Studies)
King's College of London, London, United Kingdom, 2006.
BA (Biological Sciences)
University of Southern California, Los Angeles, CA, 2007.
BA (International Relations)
University of Southern California, Los Angeles, CA, 2007.
MS (Biohazardous Threat Agents and Emerging Infectious Diseases)
Georgetown University, Washington, DC, 2008.
MD
Drexel University, College of Medicine, Philadelphia, PA, 2013.
Certificat (Global Health Delivery Intensive Certificate)
Harvard School of Public Health, Boston MA, 2014.
MSHP (Healthcare Quality and Safety concentration)
University of Pennsylvania, Philadelphia, PA, 2019.
Description of Clinical Expertise
Focus on infections due to substance use, HIV, endocarditis, and opioid use disorderDescription of Research Expertise
Improving care for under-served populations and issues related to quality of care for HIV positive patients and patients with infections secondary to substance use.Selected Publications
Richard Lueking, Wenjing Wei, Norman S. Mang, Jessica K. Ortwine, Jessica Meisner: Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital. Microbiology Spectrum. ASM Journals, Dec 2022.Jain MK, De Lemos JA, McGuire DK, Ayers C, Eitson JL, Sanchez CL, Kamel D, Meisner JA, Thomas EV, Hegde AA, Mocherla S, Strebe JK, Li X, Williams NS, Xing C, Ahmed MS, Wang P, Sadek HA, Schoggins JW.: Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial. Front Pharmacol 13: 1020123, Sep 2022.
Kruti Yagnik, Jessica Meisner: Laboratory Detection Strategies: Diagnostics and Diagnosis, In: Fundamentals of HIV Medicine 2022 Edition. AAHIVM, W David Hardy 2022.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators.: REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. N Engl J Med 385: e81, Dec 2021.
Wenjing Wei, PharmD, BCPS-AQID, Norman Mang, PharmD, BCIDP, Jessica Ortwine, PharmD, BCPS-AQID, Jessica A Meisner, MD, MS, MSHP, Richard Lueking, MD: Evaluation of the Impact of Dalbavancin Usage on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital. Open Forum Infectious Diseases 8(supplement 1): s168, November 2021.
Kalil, A. C., Mehta, A. K., Patterson, T. F., Erdmann, N., Gomez, C. A., Jain, M. K., ... & Colombo, R. E. : Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine 9(12): 1365-1376, 12 2021.
Pezo-Salazar, A and Meisner, J.A. : Laboratory Detection Strategies: Diagnostics and Diagnosis, In: Fundamentals of HIV Medicine 2021 Edition. AAHIVM, W David Hardy 2021.
Meisner JA, Anesi J, Chen X, Grande D.: Changes in Infective Endocarditis Admissions in Pennsylvania During the Opioid Epidemic. Clin Infect Dis 71: 1664-1670, Oct 2020.
Meisner, J; Anesi, J.; Chen, X., and Grande, D.: Changes in infective endocarditis admissions in Pennsylvania during the opioid epidemic Clinical Infectious Diseases Epublished: 71(7):1664-1670, October 2020 Notes: https://doi.org/10.1093/cid/ciz1038.
Schranz A J, Meisner, J A. : Linking prescription opioids and infectious diseases. The Lancet Infectious Diseases 20(4): 392-394, April 2020 Notes: doi: 10.1016/S1473-3099(19)30754-6. Epub 2020 Jan 22. PMID: 31981473.